Why Fresenius Medical Care Stock Might be a Great Pick
Werte in diesem Artikel
One stock that might be an intriguing choice for investors right now is Fresenius Medical Care AG FMS. This is because this security in the Medical - Instruments space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. This is important because, often times, a rising tide will lift all boats in an industry, as there can be broad trends taking place in a segment that are boosting securities across the board. This is arguably taking place in the Medical - Instruments space as it currently has a Zacks Industry Rank of 66 out of more than 250 industries, suggesting it is well-positioned from this perspective, especially when compared to other segments out there. Meanwhile, Fresenius Medical Care is actually looking pretty good on its own too. The firm has seen solid earnings estimate revision activity over the past month, suggesting analysts are becoming a bit more bullish on the firm’s prospects in both the short and long term. Fresenius Medical Care AG Price and Consensus Fresenius Medical Care AG price-consensus-chart | Fresenius Medical Care AG QuoteIn fact, over the past month, current quarter estimates have risen from 44 cents per share to 45 cents per share, while current year estimates have risen from $2.01 per share to $2.11 per share. This has helped FMS to earn a Zacks Rank #1 (Strong Buy), further underscoring the company’s solid position. You can see the complete list of today’s Zacks #1 Rank stocks here.So, if you are looking for a decent pick in a strong industry, consider Fresenius Medical Care. Not only is its industry currently in the top third, but it is seeing solid estimate revisions as of late, suggesting it could be a very interesting choice for investors seeking a name in this great industry segment.Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Fresenius Medical Care AG & Co. KGaA (FMS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf :be
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf :be
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Fresenius SE & Co. KGaA (St.)
Analysen zu Fresenius SE & Co. KGaA (St.)
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2025 | Fresenius SECo Overweight | JP Morgan Chase & Co. | |
22.04.2025 | Fresenius SECo Buy | Deutsche Bank AG | |
22.04.2025 | Fresenius SECo Overweight | Barclays Capital | |
07.04.2025 | Fresenius SECo Market-Perform | Bernstein Research | |
26.03.2025 | Fresenius SECo Buy | UBS AG |
Datum | Rating | Analyst | |
---|---|---|---|
23.04.2025 | Fresenius SECo Overweight | JP Morgan Chase & Co. | |
22.04.2025 | Fresenius SECo Buy | Deutsche Bank AG | |
22.04.2025 | Fresenius SECo Overweight | Barclays Capital | |
26.03.2025 | Fresenius SECo Buy | UBS AG | |
21.03.2025 | Fresenius SECo Buy | Jefferies & Company Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
07.04.2025 | Fresenius SECo Market-Perform | Bernstein Research | |
26.02.2025 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
04.02.2025 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
08.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. | |
06.11.2024 | Fresenius SECo Neutral | Goldman Sachs Group Inc. |
Datum | Rating | Analyst | |
---|---|---|---|
02.11.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
30.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.07.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
17.03.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. | |
23.02.2021 | Fresenius SECo Underperform | Jefferies & Company Inc. |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius SE & Co. KGaA (St.) nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen